Causes of sleep apnoea in people with and without multiple sclerosis (MS)

RESEARCH STUDY

The study aims to investigate:

The causes of sleep apnoea are different in people with multiple sclerosis (MS) compared to people without MS.

You can help our research if you:

Are aged over 18
Stable MS with no relapses in the past month
Have been diagnosed with sleep apnoea (or suspected sleep apnoea).
Have no cardiovascular disease or neurological disorders other than MS
Are not pregnant or breast-feeding

If you take part in the study you would:

Visit NeuRA in Randwick 2 times over 2 weeks for overnight sleep studies
We will apply a range of stick on recording devices
Participate in awake breathing tests
Be monitored overnight
Some invasive nose, tongue and throat sensors will be used

Please contact:

Andrea or Carolin

sleeplab@neura.edu.au

9399 1886

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

The importance of medical research - Professor Peter Schofield AO

On August 11 2019, 54 people took on the City2Surf for Neuroscience Research Australia (NeuRA). The event is the world’s largest fun run with 80,000 participants taking on the 14km course, which stretches from Hyde Park in central Sydney to the iconic Bondi Beach. NeuRA thanks all of its fundraisers, who raised an incredible $30,903. This funding will further NeuRA’s […]

Gabrielle Hunter

NeuRA BLOG: Team NeuRA at the City2Surf 2019

Entering the vital next phase in our fight against Alzheimer’s

‘Take care of all your memories… for you cannot relive them.’ The words of the American singer-songwriter Bob Dylan are so true… for you cannot relive them. For Amanda, a big turning point was the moment a test showed she carried the family’s early-onset Alzheimer’s gene. Would she see her 50th birthday? And would her most treasured family memories fade away like an old album of yellowing photos? Another turning point was her vow to take part in a large clinical trial in the hope of sparing her children’s lives, since they had a 50% chance of carrying the gene too. “Sign me up... I’m your girl”, she said. The day-by-day pressure on Amanda’s life in her Alzheimer’s clinical trial has been enormous. And her bravery and endurance only heighten the pressure on us to keep up – and intensify – the fight against the hideous disease of Alzheimer’s.

Donor Morning Tea

Twins hold the key to protecting ourselves against mental illness

The Genomics of Intellectual Disability

Neurocognitive disorders are one of the largest unmet challenges in healthcare, due to their lifelong nature, high management costs, prevalence and frequent recurrence within families. The objectives of this research will be to enhance fundamental knowledge about the genetic basis of neurocognition and the investigation of targeted treatment strategies in relation to biological pathways. Non-coding and copy number variation mechanisms will be explored along, with a study on variable expressivity and non-penetrance in specific syndromes. It will apply genomic technologies to a cohort of at least 200 families with neurocognitive disorders, develop bioinformatics tools and implement functional studies using induced pluripotent stem cells and CRISPR/Cas9 to explore the heterogeneity underlying the genetic aetiology of intellectual disability. The outcomes of this research could enable improvements in clinical phenotyping, genomic diagnosis, common data analysis and reporting standards.

SUPPORT OUR RESEARCH